JP2012527887A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527887A5
JP2012527887A5 JP2012512547A JP2012512547A JP2012527887A5 JP 2012527887 A5 JP2012527887 A5 JP 2012527887A5 JP 2012512547 A JP2012512547 A JP 2012512547A JP 2012512547 A JP2012512547 A JP 2012512547A JP 2012527887 A5 JP2012527887 A5 JP 2012527887A5
Authority
JP
Japan
Prior art keywords
gene
group
cells
clone
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012512547A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012527887A (ja
JP5777113B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2010/003620 external-priority patent/WO2010137348A1/en
Publication of JP2012527887A publication Critical patent/JP2012527887A/ja
Publication of JP2012527887A5 publication Critical patent/JP2012527887A5/ja
Application granted granted Critical
Publication of JP5777113B2 publication Critical patent/JP5777113B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012512547A 2009-05-29 2010-05-28 人工多能性幹細胞のクローンの選択方法 Expired - Fee Related JP5777113B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21736209P 2009-05-29 2009-05-29
US61/217,362 2009-05-29
PCT/JP2010/003620 WO2010137348A1 (en) 2009-05-29 2010-05-28 Method for selecting clone of induced pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2012527887A JP2012527887A (ja) 2012-11-12
JP2012527887A5 true JP2012527887A5 (enExample) 2013-08-08
JP5777113B2 JP5777113B2 (ja) 2015-09-09

Family

ID=43222474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012512547A Expired - Fee Related JP5777113B2 (ja) 2009-05-29 2010-05-28 人工多能性幹細胞のクローンの選択方法

Country Status (4)

Country Link
US (1) US9005975B2 (enExample)
EP (1) EP2438159B1 (enExample)
JP (1) JP5777113B2 (enExample)
WO (1) WO2010137348A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2690554T3 (es) 2008-03-17 2018-11-21 The Scripps Research Institute Enfoques químicos y genéticos combinados para la generación de células madre pluripotentes inducidas
EP2321406B1 (en) * 2008-08-05 2014-12-10 Keio University Method for selecting secondary neurosphere derived from induced pluripotent stem cell
ES2645869T3 (es) 2008-12-17 2017-12-11 The Scripps Research Institute Generación y mantenimiento de células madre
WO2011027908A1 (en) 2009-09-02 2011-03-10 Kyoto University Method of selecting safe pluripotent stem cells
ES2638464T3 (es) * 2009-10-16 2017-10-20 The Scripps Research Institute Inducción de células pluripotentes
ES2539487T3 (es) 2009-11-04 2015-07-01 Cellular Dynamics International, Inc. Reprogramación episómica con compuestos químicos
AU2011235212B2 (en) 2010-03-31 2014-07-31 The Scripps Research Institute Reprogramming cells
EP3399026B1 (en) 2010-06-14 2024-06-26 The Scripps Research Institute Reprogramming of cells to a new fate
JP5936134B2 (ja) 2010-06-15 2016-06-15 国立大学法人京都大学 ヒト人工多能性幹細胞の選択方法
CN106893692B (zh) 2010-12-22 2021-11-26 菲特治疗公司 用于单细胞分选与增强ipsc重新编程的细胞培养平台
CN107988381B (zh) 2011-07-25 2021-05-28 国立大学法人京都大学 筛选诱导的多能干细胞的方法
EP3095864B1 (en) * 2014-01-14 2020-04-15 Kagoshima University Method for labelling cancerization-causing cell in stem cells
SG10201807292YA (en) 2014-03-04 2018-09-27 Fate Therapeutics Inc Improved reprogramming methods and cell culture platforms
AU2016338680B2 (en) 2015-10-16 2022-11-17 Fate Therapeutics, Inc. Platform for the induction and maintenance of ground state pluripotency
KR101783977B1 (ko) 2016-12-30 2017-10-10 제일약품주식회사 기형종 형성이 억제된 전분화능 줄기세포 유래 신경 전구체구의 제조 방법
WO2018232079A1 (en) 2017-06-14 2018-12-20 Daley George Q Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
MX2022008648A (es) 2020-01-23 2022-12-15 The Children´S Medical Center Corp Diferenciacion de celulas t sin estroma a partir de celulas madre pluripotentes humanas.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3660601B2 (ja) 2001-03-30 2005-06-15 独立行政法人科学技術振興機構 胚性幹細胞からの神経幹細胞、運動ニューロン及びｇａｂａ作動性ニューロンの製造法
AUPS225402A0 (en) 2002-05-10 2002-06-13 Bresagen Limited Modified cell production
US7964401B2 (en) 2004-02-19 2011-06-21 Kyoto University Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3
AU2006304390A1 (en) 2005-10-17 2007-04-26 Academia Sinica Pulmonary stem cells, related methods and kits
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
KR101420740B1 (ko) 2005-12-13 2014-07-17 교또 다이가꾸 핵초기화 인자
KR100794362B1 (ko) 2006-02-27 2008-01-15 주식회사 임젠 Ｎａｎｏｇ를 이용한 아스트로사이트의 신경줄기세포로의역분화
EP2137296A2 (en) 2007-03-23 2009-12-30 Wisconsin Alumni Research Foundation Somatic cell reprogramming
KR101564044B1 (ko) 2007-10-31 2015-10-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 핵초기화 방법
EP2072618A1 (en) * 2007-12-14 2009-06-24 Johannes Gutenberg-Universität Mainz Use of RNA for reprogramming somatic cells
ES2690554T3 (es) 2008-03-17 2018-11-21 The Scripps Research Institute Enfoques químicos y genéticos combinados para la generación de células madre pluripotentes inducidas
EP2321406B1 (en) 2008-08-05 2014-12-10 Keio University Method for selecting secondary neurosphere derived from induced pluripotent stem cell
JP5936134B2 (ja) 2010-06-15 2016-06-15 国立大学法人京都大学 ヒト人工多能性幹細胞の選択方法

Similar Documents

Publication Publication Date Title
JP2012527887A5 (enExample)
Orkin et al. Chromatin connections to pluripotency and cellular reprogramming
US10564167B2 (en) Method for detecting cells
Comes et al. L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation
Völkel et al. Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3
NZ616646A (en) Synthetic genes
WO2011135194A3 (en) Method for diagnosing risk of type 1 diabetes and for preventing onset of type 1 diabetes
RU2017100434A (ru) Набор или устройство для обнаружения рака молочной железы и способ обнаружения
WO2009070767A3 (en) Systemic instigation systems to study tumor growth or metastasis
NZ704322A (en) Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EA201591411A1 (ru) Системы и способы для поддержки клинических решений
Beck et al. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression
WO2012083969A3 (en) Microrna for diagnosis of pancreatic cancer
WO2011027310A8 (en) Novel tumor markers
Watanabe et al. Virological characterization of the 2022 outbreak‐causing monkeypox virus using human keratinocytes and colon organoids
WO2011122857A3 (ko) 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
JP6143265B2 (ja) 人工多能性幹細胞の選別方法
CA2835730C (en) Molecular markers in prostate cancer
WO2011027308A8 (en) Novel tumor markers
NZ609567A (en) Markers of endothelial progenitor cells and uses thereof
WO2012032519A3 (en) Methods of diagnosing parkinson's disease
Masuda et al. Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?
WO2012101219A3 (en) Complex mirna sets as novel biomarkers for lung diseases
WO2009114673A3 (en) Methods for production of atrial progenitors and their differentiation into smooth muscle cells and cardiomyocytes
MX2013012648A (es) Metodo para determinar hipoxia clinicamente relevante en cancer.